4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-035138
Chief Commercial Officer sold 25,000 shares at $21.40 ($534,930)
- Chief Commercial Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean Chief Commercial Officer | 2021-09-01 | Option exercise | +25,000 | $3.29 | $82,250 | 65,024 | D |
| Maduck Sean Chief Commercial Officer | 2021-09-01 | Sale | −25,000 | $21.40 | $534,930 | 40,024 | D |
| Derivatives | |||||||
| Maduck Sean Chief Commercial Officer | 2021-09-01 | Option exercise · Stock Option (Right to Buy) | −25,000 | 147,602 | D | ||
| Open-market sales · 25,000 sh · avg $21.40 · $534,930 | |||||||
Loading xslF345X03/doc4.xml…